Children receiving antithyroid drugs showed significant improvement in symptoms of exophthalmic goiter, and overall treatment outcomes were favorable.
The study documented changes in hyperthyroidism indicators, with over 70% of participants showing reduced symptoms after treatment.
Clinical trial utilized antithyroid drugs as the main intervention, assessing their effectiveness over a six-month period in children.
These findings highlight the potential of antithyroid drugs in managing exophthalmic goiter, but further research is necessary for broader application.